亚太地区急性胰臟炎市场预测至 2030 年 - 区域分析 - 按产品、原因和最终用户

2022年亚太地区急性胰臟炎市值为6.0735亿美元，预计2030年将达到10.7606亿美元；预计 2022 年至 2030 年CAGR为 7.4%。

急性胰臟炎研发活动和宣传项目数量激增，推动亚太地区急性胰臟炎市场的发展

全球正在进行广泛的研究，以调查急性胰臟炎的病因、进展和治疗。国家胰臟基金会 (NPF) 提供多项研究资助，每个计画价值约 5 万美元。迄今为止，NPF 已为 133 个突破性研究项目提供了超过 500 万美元的资金。授予为期一年的补助金，用于诊断和/或治疗胰臟炎、胰臟癌或小儿胰臟炎。

此外，国际上正在进行一些努力来定义急性胰臟炎的流行病学和病理生理学。因此，针对急性胰臟炎开发有效疗法（透过直接和间接手段）的研发活动和宣传计画预计将为亚太地区急性胰臟炎市场的公司带来丰硕成果。

亚太地区急性胰臟炎市场概况

亚太地区急性胰臟炎市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。市场成长归因于胰臟炎病例增加、研究人员开发胰臟炎治疗方法以及政府努力提高民众意识等因素。此外，与酒精相关的胰臟炎病例也推动了该地区市场的成长。近年来，我国胰臟炎的盛行率呈现上升趋势。 2022年发表的《1990年至2019年中国胰臟炎负担及相关危险因子》研究显示，近年来饮酒已成为我国胰臟炎疾病负担的重要原因。在中国，酒精性胰臟炎的病例与10年前相比显着增加。在该国，1990年胰臟炎病例数为380,018例，2019年为493,765例。1990年至2019年，因胰臟炎死亡的总人数也有所增加，1990年为8,976例，2019年为例10,664例。201999年为例。年，胰臟炎死亡人数全国因酒精性胰臟炎死亡3,327.29例，占胰臟炎死亡总数的31.20%。

亚太地区急性胰臟炎市场收入及 2030 年预测（百万美元）

亚太地区急性胰臟炎市场细分

亚太地区急性胰臟炎市场按产品、原因、最终用户和国家进行细分。

根据产品类型，亚太地区急性胰臟炎市场分为药物、诊断等。 2022年，诊断细分市场占据最大市场份额。

根据方法，亚太地区急性胰臟炎市场分为胆结石、酗酒、遗传性疾病、感染等。 2022 年，胆结石细分市场占据最大的市场份额。

根据最终用户，亚太地区急性胰臟炎市场分为医院、诊断实验室、门诊手术中心等。 2022 年，医院细分市场占据最大市场份额。

依国家/地区划分，亚太地区急性胰臟炎市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年，中国主导亚太地区急性胰臟炎市场。

Abbott Laboratories、Baxter International Inc、Boston Scientific Corp、Dynavax Technologies Corp、Fresenius Kabi AG、GE HealthCare Technologies Inc、Koninklijke Philips NV、Medtronic Plc 和 Samsung Healthcare 是亚太地区急性胰臟炎市场上的一些领先公司。

主要市场驱动因素
- 急性胰臟炎导致胰臟癌病例增加
- 急性胰臟炎后糖尿病发生率上升
主要市场限制
- 胰臟炎和胰臟癌治疗的副作用
主要市场机会
- 急性胰臟炎的研发活动和宣传项目数量激增
未来的趋势
- 特异性急性胰臟炎治疗的进展
影响分析：

第 6 章：急性胰臟炎市场 - 亚太市场分析

亚太地区急性胰臟炎市场收入，2022 - 2030

第 7 章：亚太地区急性胰臟炎市场 - 收入和 2030 年预测 - 按产品分类

概述
2022 年及 2030 年亚太地区急性胰臟炎市场收入份额（按产品划分）（%）
药物
诊断
其他的

第 8 章：亚太地区急性胰臟炎市场 - 收入和 2030 年预测 - 按原因

概述
2022 年和 2030 年亚太地区急性胰臟炎市场收入份额（按原因划分）
胆结石
酗酒
遗传性疾病
感染
其他的

第 9 章：亚太地区急性胰臟炎市场 - 收入和 2030 年预测 - 按最终用户

概述
2022 年及 2030 年亚太地区急性胰臟炎市场收入份额（按最终用户）（%）
医院
诊断实验室
门诊手术中心
其他的

第 10 章：亚太地区急性胰臟炎市场 - 国家分析

概述

第 11 章：亚太地区急性胰臟炎市场-产业格局

概述
亚太地区急性胰臟炎市场的成长策略
无机成长策略
- 概述
有机成长策略
- 概述

第 12 章：公司简介

Abbott Laboratories
GE HealthCare Technologies Inc
Samsung Healthcare
Koninklijke Philips NV
Baxter International Inc
Dynavax Technologies Corp
Fresenius Kabi AG
Medtronic Plc
Boston Scientific Corp

第 13 章：附录

Product Code: BMIRE00029216

The Asia Pacific acute pancreatitis market was valued at US$ 607.35 million in 2022 and is expected to reach US$ 1,076.06 million by 2030; it is estimated to grow at a CAGR of 7.4% from 2022 to 2030.

Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis Fuels the Asia Pacific Acute Pancreatitis Market

Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis.

Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the Asia Pacific acute pancreatitis market.

Asia Pacific Acute Pancreatitis Market Overview

The Asia Pacific acute pancreatitis market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth is attributed to factors including rising cases of pancreatitis, researchers to develop a treatment for pancreatitis, and government efforts to raise awareness among the population. In addition, alcohol-related pancreatitis cases also fuel the growth of the market in the region. The prevalence of pancreatitis has shown an upward trend in recent years in China. According to a study titled "Burden of Pancreatitis and associated risk factors in China, 1990 to 2019," published in 2022, alcohol consumption has become an important cause in the disease burden of pancreatitis in recent years in the country. In China, cases of alcoholic pancreatitis are significantly higher compared to 10 years ago. In the country, the number of pancreatitis cases was 380,018 in 1990 and 493,765 in 2019. From 1990 to 2019, the total number of deaths due to pancreatitis also increased, accounting for 8,976 in 1990 and 10,664 in 2019. In 2019, the number of deaths due to alcohol-related pancreatitis was 3,327.29 in the country, accounting for 31.20% of the total deaths due to pancreatitis.

Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Asia Pacific Acute Pancreatitis Market Segmentation

The Asia Pacific acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the Asia Pacific acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on method, the Asia Pacific acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the Asia Pacific acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific acute pancreatitis market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific acute pancreatitis market in 2022.

Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the Asia Pacific acute pancreatitis market.

5.1 Key Market Drivers
- 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
- 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
- 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
- 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
- 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:

6. Acute Pancreatitis Market - Asia Pacific Market Analysis

6.1 Asia Pacific Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

7.1 Overview
7.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
- 7.3.1 Overview
- 7.3.2 Medications: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Asia Pacific Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
7.4 Diagnosis
- 7.4.1 Overview
- 7.4.2 Diagnosis: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 Asia Pacific Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

8.1 Overview
8.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
- 8.3.1 Overview
- 8.3.2 Gallstones: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
- 8.4.1 Overview
- 8.4.2 Alcoholism: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
- 8.5.1 Overview
- 8.5.2 Genetic Disorders: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
- 8.6.1 Overview
- 8.6.2 Infections: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Acute Pancreatitis Market - Country Analysis

10.1 Overview

11. Asia Pacific Acute Pancreatitis Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Asia Pacific Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Samsung Healthcare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Dynavax Technologies Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Fresenius Kabi AG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boston Scientific Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

List Of Tables

Table 1. Asia Pacific Acute Pancreatitis Market Segmentation
Table 2. Asia Pacific Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 6. China: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 7. China: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 8. China: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 11. Japan: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 12. Japan: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. India: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 15. India: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 16. India: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 17. India: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 18. India: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 23. Australia: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 24. South Korea: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 28. South Korea: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 34. Recent Inorganic Growth Strategies in the Asia Pacific Acute Pancreatitis Market
Table 35. Recent Organic Growth Strategies in the Asia Pacific Acute Pancreatitis Market
Table 36. Glossary of Terms, Asia Pacific Acute Pancreatitis Market

List Of Figures

Figure 1. Asia Pacific Acute Pancreatitis Market Segmentation, By Country
Figure 2. Asia Pacific Acute Pancreatitis Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Asia Pacific Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Asia Pacific Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 21. Asia Pacific Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. China: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Japan: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. India: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Australia: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. South Korea: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Growth Strategies in the Asia Pacific Acute Pancreatitis Market

亚太地区急性胰臟炎市场预测至 2030 年 - 区域分析 - 按产品、原因和最终用户

Asia Pacific Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

第 4 章：亚太地区急性胰臟炎市场格局

第 5 章：亚太地区急性胰臟炎市场 - 主要产业动态